Entering text into the input field will update the search result below

MAC grants favorable LCD for MDxHealth's SelectMDx test

Aug. 26, 2019 7:17 AM ETMDxHealth SA (MDXH) StockMDXHBy: SA News Team
  • MDxHealth SA (OTCPK:MXDHF) announces that Palmetto GBA, a Medicare Administrative Contractor (MAC) has issued a draft local coverage determination (LCD) for the SelectMDx for Prostate Cancer test.
  • The draft LCD recommends coverage of the test for qualified Medicare patients throughout the U.S.
  • SelectMDx for Prostate Cancer is a urine-based, molecular diagnostic test that offers a non-invasive liquid biopsy method to assess a patient's risk for prostate cancer.

Recommended For You

More Trending News

About MDXH Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MDXH--
MDxHealth SA